Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
American Thoracic Society
2017
|